WASHINGTON, D.C. (May 24, 2017) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today released the following statement on the appointment of Vishal Amin as Intellectual Property Enforcement Coordinator.
“PhRMA appreciates the priority the President has placed on filling the position of Intellectual Property Enforcement Coordinator (IPEC). Effective protection of patents and other intellectual property has helped make America a global leader in the research and development of new treatments and cures for patients. PhRMA looks forward to working with Vishal Amin and the IPEC team to grow that leadership and the more than 4.5 million jobs innovative biopharmaceutical manufacturers support across the country.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.